Carbinoxamine maleate 4 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 60 mg per 5 mL Oral Syrup
RxNorm 1010946
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1010946 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbinoxamine maleate 4 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 60 mg per 5 mL Oral Syrup.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbinoxamine maleate 0.8 mg/ML / dextromethorphan hydrobromide 3 mg/ML / pseudoephedrine hydrochloride 12 mg/ML Oral Solution
(Atom ID: 12344069)
SY
Synonym (SY):
Carbinoxamine maleate 4 mg / dextromethorphan hydrobromide 15 mg / pseudoephedrine hydrochloride 60 mg per 5 mL Oral Syrup
(Atom ID: 3802214)
PT
Designated preferred name (PT):
Carbinoxamine maleate 800 microgram/mL and dextromethorphan hydrobromide 3 mg/mL and pseudoephedrine hydrochloride 12 mg/mL oral solution
(Atom ID: 11435714)
FN